Financial Architects, Inc Pacira Bio Sciences, Inc. Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $36,167 - $47,442	-989 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$36.47 - $42.17 $36,068 - $41,706	989 New	989 $38,000
Q1 2019 May 03, 2019	SELL	$36.47 - $42.17 $41,211 - $47,652	-1,130 Closed	0 $0
Q4 2018 Feb 01, 2019	SELL	$41.31 - $52.16 $12,806 - $16,169	-310 Reduced 21.53%	1,130 $49,000
Q3 2018 Oct 29, 2018	SELL	$32.85 - $52.0 $9,263 - $14,664	-282 Reduced 16.38%	1,440 $71,000
Q2 2018 Aug 03, 2018	BUY	$27.5 - $39.8 $47,355 - $68,535	1,722 New	1,722 $55,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.